The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCOP.
BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/
To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.
The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.
In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.
Target Audience: These recertification activities are intended for board-certified pharmacists seeking to update their knowledge and skills in:
- The background of Ph-like ALL, the current treatment strategies, a resultant health disparity for Latino/Latina patients with ALL, and areas of ongoing and needed research
- The incorporation of targeted agents to aid in effectively managing gastrointestinal (GI) malignancies
Philadelphia-like Acute Lymphoblastic Leukemia: Understanding and Closing a Health Disparity - BCOP CreditActivity Number: 0217-9999-25-152-H01-P
Contact Hour(s): 2.00
Activity Type: Application BasedLearning ObjectivesPhiladelphia-like Acute Lymphoblastic Leukemia: Understanding and Closing a Health Disparity
- Discuss the underlying pathophysiology, epidemiology, and diagnostic approach to Acute Lymphoblastic Leukemia.
- Compare the treatment outcomes of Ph-like Acute Lymphoblastic Leukemia to other subtypes of Acute Lymphoblastic Leukemia.
- Design an evidence-based treatment regimen for a patient with newly diagnosed Ph-like Acute Lymphoblastic Leukemia.
- Analyze the disparity in treatment outcomes for Latino/Latina patients with Acute Lymphoblastic Leukemia.
- Assess unmet needs and areas of ongoing research for the treatment of Latino/Latina patients with Ph-like Acute Lymphoblastic Leukemia.
|
FISHing for Targets: Updates in GI Malignancies - BCOP CreditActivity Number: 0217-9999-25-153-H01-P
Contact Hour(s): 2.00
Activity Type: Application BasedLearning ObjectivesFISHing for Targets: Updates in GI Malignancies
- Review updates in treatment of GEJ, gastric and colorectal cancers.
- Discuss targetable biomarkers within GI malignancies.
- Review primary literature for targeted agents recently FDA approved for GI malignancies.
- Implement toxicity management strategies for targeted agents recently FDA approved for management of GI malignancies.
- Identify appropriate treatments for patients with GI malignancies through patient cases.
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.